Related Experiment Video
Updated: Feb 17, 2026

In Vitro Cultivation Techniques for Modeling Liver Organogenesis, Building Assembloids, and Designing Synthetic Tissues using Human Cell Lines
Published on: April 18, 2025
Snail mediates crosstalk between TGFβ and LXRα in hepatocellular carcinoma
Claudia Bellomo1,2, Laia Caja1,2, Isabel Fabregat3
1Department of Medical Biochemistry and Microbiology, Science for Life Laboratory, Box 582, Biomedical Center, Uppsala University, SE-75123, Uppsala, Sweden.
Abstract:
Understanding the complexity of changes in differentiation and cell survival in hepatocellular carcinoma (HCC) is essential for the design of new diagnostic tools and therapeutic modalities. In this context, we have analyzed the crosstalk between transforming growth factor β (TGFβ) and liver X receptor α (LXRα) pathways. TGFβ is known to promote cytostatic and pro-apoptotic responses in HCC, and to facilitate mesenchymal differentiation. We here demonstrate that stimulation of the nuclear LXRα receptor system by physiological and clinically useful agonists controls the HCC response to TGFβ. Specifically, LXRα activation antagonizes the mesenchymal, reactive oxygen species and pro-apoptotic responses to TGFβ and the mesenchymal transcription factor Snail mediates this crosstalk. In contrast, LXRα activation and TGFβ cooperate in enforcing cytostasis in HCC, which preserves their epithelial features. LXRα influences Snail expression transcriptionally, acting on the Snail promoter. These findings propose that clinically used LXR agonists may find further application to the treatment of aggressive, mesenchymal HCCs, whose progression is chronically dependent on autocrine or paracrine TGFβ.
Insights
Liver X receptor alpha (LXRα) activation counteracts transforming growth factor beta (TGFβ)-induced mesenchymal changes in liver cancer. LXRα agonists may treat aggressive hepatocellular carcinoma (HCC) dependent on TGFβ.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Hepatocellular carcinoma (HCC) progression involves complex changes in cell differentiation and survival.
- Transforming growth factor beta (TGFβ) signaling is implicated in promoting apoptosis and mesenchymal transition in HCC.
- Understanding the interplay between TGFβ and other signaling pathways is crucial for developing novel HCC therapies.
Purpose of the Study:
- To investigate the crosstalk between transforming growth factor beta (TGFβ) and liver X receptor alpha (LXRα) pathways in hepatocellular carcinoma (HCC).
- To determine how LXRα activation modulates the cellular responses to TGFβ in HCC.
- To explore the therapeutic potential of LXRα agonists in aggressive HCC subtypes.
Main Methods:
- Analysis of signaling pathway crosstalk in HCC cell models.
- Stimulation of the LXRα receptor system with agonists.
- Assessment of cellular responses including differentiation, apoptosis, and gene expression.
- Investigation of the role of the transcription factor Snail in mediating pathway interactions.
- Examination of LXRα's transcriptional control over the Snail promoter.
Main Results:
- LXRα activation antagonizes TGFβ-induced mesenchymal differentiation, reactive oxygen species production, and apoptosis in HCC.
- The mesenchymal transcription factor Snail mediates the crosstalk between LXRα and TGFβ pathways.
- LXRα activation and TGFβ cooperate to enforce cytostasis, preserving epithelial features in HCC.
- LXRα transcriptionally regulates Snail expression by acting on the Snail promoter.
Conclusions:
- LXRα activation offers a mechanism to counteract pro-mesenchymal and pro-apoptotic effects of TGFβ in HCC.
- The findings highlight a novel role for LXRα in regulating Snail expression and HCC cell fate.
- Clinically relevant LXRα agonists may represent a therapeutic strategy for aggressive, mesenchymal HCCs driven by TGFβ signaling.
Related Concept Videos
TGF - β Signaling Pathway
Hedgehog Signaling Pathway
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...

